Can alpha-ketoglutarate (AKG) dietary supplementation improve health and treat age-related diseases in humans?
Calcium Alpha-Ketoglutarate, a review (Trends in Endocrinology & Metabolism 2021, PMID 34952764) — alpha-ketoglutarate shows promise in animal studies for healthspan extension, but more recent human research is needed to confirm its benefits for aging and age-related diseases. No numeric effect size is reported for Calcium Alpha-Ketoglutarate in the source abstract.
Source: Trends in Endocrinology & Metabolism 2021, PMID 34952764 ↗ · Research map · How Magellan grades evidence · evidence confidence: low
Trends in Endocrinology & Metabolism · 2021 · PMID 34952764 · DOI 10.1016/j.tem.2021.11.003
Alpha-ketoglutarate shows promise in animal studies for healthspan extension, but more recent human research is needed to confirm its benefits for aging and age-related diseases.
The question
Can alpha-ketoglutarate (AKG) dietary supplementation improve health and treat age-related diseases in humans?
What they tested
The pleiotropic functions of AKG, including its roles as an antioxidant and in metabolic, epigenetic, and immune regulation, suggest it may extend human healthspan and treat age-related diseases.
How they did it
This is a review article discussing the regulatory role of AKG in aging and its potential therapeutic use in humans. It references past studies in worms, mice, and a few human studies from the 1980s and 1990s.
What they found
Recent studies in worms and mice support the concept that AKG may extend healthspan. Older human studies suggested potential benefits of AKG in muscle growth, wound healing, and faster post-surgery recovery. However, there are no recently published human studies demonstrating AKG's role in treating aging and age-related diseases.
What it means
While AKG shows promise in animal models and older human studies suggested some benefits, further clinical studies are required to better understand its role in treating aging and age-related diseases in humans.
Limitations
There is a lack of recently published human studies demonstrating the role of AKG in treating aging and age-related diseases.
The paper at a glance
| Title | Alpha-Ketoglutarate dietary supplementation to improve health in humans |
|---|---|
| Journal | Trends in Endocrinology & Metabolism |
| Year | 2021 |
| PMID | 34952764 ↗ |
| DOI | 10.1016/j.tem.2021.11.003 ↗ |
| Topic | Pain, nerves & musculoskeletal medicine |
Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗
Where Magellan uses this paper
This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.
All-in-One Longevity Formulation
Several of NOVOS Core's ingredients have genuine, though mostly early-stage, human or animal evidence relevant to aging: trials of GlyNAC (glycine plus N-acetylcysteine) improved oxidative stress, mitochondrial function, strength and walking performance in older adults — though at glycine doses far above what the…
Calcium Alpha-Ketoglutarate (Ca-AKG)
AKG sits at the intersection of energy metabolism and epigenetic regulation: Krebs-cycle intermediates such as AKG act as cofactors for the enzymes that add and remove methyl marks on DNA and histones.
NOVOS Core is a multi-ingredient dietary supplement marketed for longevity that combines about a dozen…
Research describes the compound or intervention studied. It is not a claim about any specific product.
Cite this page
These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.
Magellan Longevity. (2026). Can alpha-ketoglutarate (AKG) dietary supplementation improve health and treat age-related diseases in humans? [Plain-English summary of Trends in Endocrinology & Metabolism 2021, PMID 34952764, DOI 10.1016/j.tem.2021.11.003]. Magellan Longevity. https://magellanlongevity.com/study/akg_human.html@misc{magellan_akg_human,
title = {Can alpha-ketoglutarate (AKG) dietary supplementation improve health and treat age-related diseases in humans?},
author = {{Magellan Longevity}},
year = {2026},
howpublished = {\url{https://magellanlongevity.com/study/akg_human.html}},
note = {Plain-English summary of PubMed PMID 34952764; DOI 10.1016/j.tem.2021.11.003; Trends in Endocrinology & Metabolism 2021. Reviewed by Gabriel Radu, DO},
urldate = {2026-08-11}
}https://magellanlongevity.com/study/akg_human.htmlRelated studies in the Magellan library
- Rejuvant, a potential life-extending compound formulation with alpha-ketoglutarate and…Aging · 2021 · PMID 34847066
- Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging…Ageing Research Reviews · 2014 · PMID 24910305
- GlyNAC supplementation in older adults improves glutathione deficiency, oxidative stress…Clin Transl Med · 2021 · PMID 33783984
- Senolytic drugs: from discovery to translationJ Intern Med · 2020 · PMID 32686219
- Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione…The Journals of Gerontology: Series A · 2022 · PMID 35975308
- The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy…GeroScience · 2022 · PMID 36482258
All 14 Magellan summaries on pain, nerves & musculoskeletal medicine →
Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →